Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Vaccines
|
June 24, 2022
Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients
Helly Hammer, Robert Hoepner, Christoph Friedli, et al.
Therapeutic Advances in Neurological Disorders
|
March 27, 2024
Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse events
Pauline Thränhardt, Admirim Veselaj, Christoph Friedli, et al.
Human Brain Mapping
|
October 17, 2022
Reliable brain morphometry from contrast-enhanced T1w-MRI in patients with multiple sclerosis
Michael Rebsamen, Richard McKinley, Piotr Radojewski, et al.
European Journal of Neurology
|
November 28, 2022
Anti-neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia-a case report and review of the literature
Anina Schwarzwald, Anke Salmen, Alejandro Xavier León Betancourt, et al.
European Journal of Neurology
|
February 23, 2023
Anti-kelchlike protein 11 antibody-associated encephalitis: Two case reports and review of the literature
Alejandro León Betancourt, Anina Schwarzwald, Alban Millonig, et al.
CNS Neuroscience & Therapeutics
|
August 17, 2022
Multidimensional phenotyping of the post-COVID-19 syndrome: A Swiss survey study
Lara Diem, Anina Schwarzwald, Christoph Friedli, et al.
Journal of Central Nervous System Disease
|
May 7, 2024
Different lymphocyte counts of multiple sclerosis patients treated with ofatumumab and ocrelizumab: A retrospective observational study
Christoph Friedli, Nik Krajnc, Helly N Hammer, et al.
Journal of Central Nervous System Disease
|
May 31, 2022
Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19
Lara Diem, Livia Fregolente-Gomes, Jan D Warncke, et al.
Therapeutic Advances in Neurological Disorders
|
October 22, 2019
Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course
Greta Zoehner, Andrei Miclea, Anke Salmen, et al.
CNS Neuroscience & Therapeutics
|
October 13, 2020
Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort
Krenar Veselaj, Nicole Kamber, Myriam Briner, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Vaccines
|
June 24, 2022
Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients
Helly Hammer, Robert Hoepner, Christoph Friedli, et al.
Therapeutic Advances in Neurological Disorders
|
March 27, 2024
Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse events
Pauline Thränhardt, Admirim Veselaj, Christoph Friedli, et al.
Human Brain Mapping
|
October 17, 2022
Reliable brain morphometry from contrast-enhanced T1w-MRI in patients with multiple sclerosis
Michael Rebsamen, Richard McKinley, Piotr Radojewski, et al.
European Journal of Neurology
|
November 28, 2022
Anti-neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia-a case report and review of the literature
Anina Schwarzwald, Anke Salmen, Alejandro Xavier León Betancourt, et al.
European Journal of Neurology
|
February 23, 2023
Anti-kelchlike protein 11 antibody-associated encephalitis: Two case reports and review of the literature
Alejandro León Betancourt, Anina Schwarzwald, Alban Millonig, et al.
CNS Neuroscience & Therapeutics
|
August 17, 2022
Multidimensional phenotyping of the post-COVID-19 syndrome: A Swiss survey study
Lara Diem, Anina Schwarzwald, Christoph Friedli, et al.
Journal of Central Nervous System Disease
|
May 7, 2024
Different lymphocyte counts of multiple sclerosis patients treated with ofatumumab and ocrelizumab: A retrospective observational study
Christoph Friedli, Nik Krajnc, Helly N Hammer, et al.
Journal of Central Nervous System Disease
|
May 31, 2022
Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19
Lara Diem, Livia Fregolente-Gomes, Jan D Warncke, et al.
Therapeutic Advances in Neurological Disorders
|
October 22, 2019
Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course
Greta Zoehner, Andrei Miclea, Anke Salmen, et al.
CNS Neuroscience & Therapeutics
|
October 13, 2020
Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort
Krenar Veselaj, Nicole Kamber, Myriam Briner, et al.
Page
of 3